Skip to main content
S&P 5007,591.70-0.58%DOW52,064.10-0.60%NASDAQ26,081.72-0.65%BTC$76,799.00-1.71%ETH$2,453.65-0.48%GOLD$4,367.20-0.91%OIL$103.26+0.76%
Smart Investors Daily
SE

NASDAQ · SENS

Senseonics Holdings, Inc.

Healthcare · Medical - Devices

$8.79

Up+$0.07 (+0.80%)

Updated Sep 11, 2026, 5:53 AM

SID Score

5.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
289.23M
P/E ratio
-4.92
Dividend yield
0.00%
52-week range
$4.79 – $11.58
Volume
452.52K
Avg. volume
486.83K

Price performance

SENS price history

1M range · 20 trading sessions · Daily adjusted prices

SENS closed at $8.79 after 20 trading sessions, up 13.71% for the selected period.

Last close
$8.79
Period change
+13.71%
Period low
$7.73
Period high
$9.94
Daily close
View OHLC price history
SENS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 10, 2026$8.61$9.13$8.45$8.79452.52K
Sep 9, 2026$9.25$9.535$8.68$8.72768.61K
Sep 8, 2026$9.61$9.6406$9.23$9.33531.18K
Sep 4, 2026$9.76$9.98$9.62$9.63425.58K
Sep 3, 2026$9.97$10.08$9.46$9.90750.55K
Sep 2, 2026$9.40$10.1495$9.3201$9.94820.92K
Sep 1, 2026$9.17$9.67$9.11$9.38855.45K
Aug 31, 2026$9.29$9.2955$9.09$9.23366.69K
Aug 28, 2026$9.39$9.62$9.24$9.33353.67K
Aug 27, 2026$9.33$9.66$9.2601$9.40359.74K
Aug 26, 2026$9.48$9.50$8.97$9.34440.58K
Aug 25, 2026$9.36$9.74$9.31$9.52598.63K
Aug 24, 2026$9.57$9.99$9.2094$9.38856.46K
Aug 21, 2026$9.24$9.735$9.06$9.711.28M
Aug 20, 2026$8.91$9.13$8.7103$8.82544.62K
Aug 19, 2026$8.71$9.19$8.71$9.111.02M
Aug 18, 2026$7.93$8.88$7.93$8.691.2M
Aug 17, 2026$7.68$8.075$7.55$8.03597.73K
Aug 14, 2026$7.74$7.94$7.60$7.81449.87K
Aug 13, 2026$7.73$8.15$7.6811$7.73809.17K

Latest SENS news

The latest Smart Investors Daily articles mentioning SENS.

Stock researchCompany · Overview

SENS research

Overview

Company profile and research snapshot.

Company profile

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$1.10
Implied upside
—
Analysts
—
SENS recent ratings
DateFirmRatingTarget
Jul 15, 2026MizuhoOutperform—
May 12, 2026HC Wainwright & Co.Buy—
May 11, 2026StifelHold—
Nov 6, 2025HC Wainwright & Co.Buy—
Nov 5, 2025BarclaysOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Aug 14, 2026

Jim Cramer Says Buy Carpenter Technology, Calls This IT Services Stock a 'Value Trap'

Cramer recommends buying Carpenter Technology (NYSE: CRS) and calls DXC Technology (NYSE: DXC) a value trap. Senseonics Holdings (NASDAQ: SENS) posts upbeat sales and Ubiquiti (NYSE: UI) reports worse-than-expected results. Hess Midstream (NYSE: HESM) is a winner while Zeta Global (NYSE: ZETA) announces a new CMO. UL Solutions (NYSE: ULS) is a potential buy and Coupang (NYSE: CPNG) is not recommended, but MercadoLibre (NASDAQ: MELI) and Amazon (NASDAQ: AMZN) are worth considering.

Yahoo · Aug 7, 2026

Senseonics Holdings, Inc. Common Stock Q2 Earnings Call Highlights

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) raised its full-year 2026 revenue and gross-margin outlook after reporting second-quarter revenue growth of approximately 120% and its highest organic gross margin to date. Net revenue for the second quarter totaled $14.5 million, compared with $

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By